Major Program
Phase 0 I II Cancer Prevention Clinical Trials Program
Research Group
Prostate and Urologic Cancer
Sponsor
National Cancer Institute (NCI)
Status
Completed
NCT ID
NCT02095145
This randomized phase II trial studies pomegranate-extract pill in preventing tumor growth in patients with prostate cancer that is limited to a certain part of the body (localized), who have chosen observation as their treatment plan. The use of pomegranate-extract pill may slow disease progression in patients with localized prostate cancer.
Intervention
Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Pomegranate-Extract Pill
Condition
PSA Level Less Than or Equal to Fifteen, PSA Level Less Than Ten, Stage I Prostate Cancer AJCC v7, Stage II Prostate Cancer AJCC v7, Stage IIA Prostate Cancer AJCC v7, Stage IIB Prostate Cancer AJCC v7
Investigators
David F Jarrard